According to Iterum Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$35.15. In 2022 the company made an earnings per share (EPS) of -HK$26.13 an increase over its 2021 EPS that were of -HK$89.75.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$35.46 | 35.67% |
2022 | -HK$26.13 | -70.88% |
2021 | -HK$89.75 | -72.13% |
2020 | -HK$321.99 | -61.18% |
2019 | -HK$829.48 | 16.48% |
2018 | -HK$712.13 | 57.64% |
2017 | -HK$451.74 |